Proprietary Boswellia serrata extract may shorten duration of acute symptoms of gastrointestinal infections, says recent study

A recently published study found that a lecithin-based delivery form of Boswellia serrata from Indena, called Casperome, may be effective in reducing the duration of acute diarrhea in subjects with gastrointestinal infections.

A recent study published in Nutrients1 found that a lecithin-based delivery form of Boswellia serrata from Indena, called Casperome, may be effective in reducing the duration of acute diarrhea in subjects with gastrointestinal infections. In the randomized, double-blind, placebo-controlled trial, 49 adults with acute diarrhea were given either placebo or 250 mg per day of the Boswellia serrata extract for five days. Results showed that supplementation with the extract demonstrated an 80% probability of recovering sooner from infection, as well as a significantly lower number of stools. There were also significant differences between the two groups in measures of abdominal pain, nausea, and global assessment of efficacy. Boswellia serrata may be effective for treating acute diarrhea because of its anti-inflammatory, antispasmodic, and antimicrobial activity.

“Boswellia serrata extract can act as a Ca2+ channels modulator and Casperome optimizes its delivery to the target organ: intestinal smooth muscles. Moreover, no side effects have been observed: Casperome counteracts motility unbalance, without slowing down the transit rate, and this is a major advantage since other agents induce constipation,” explained Antonella Riva, Indena’s head of product innovation and development, in a press release.

Reference

  1. Giacosa A et al. “Positive effects of a lecithin-based delivery form of Boswellia serrata extract in acute diarrhea of adult subjects.” Nutrients, vol. 12 (2022): 1858